Brief: Champions Oncology Q2 adjusted EPS USD -0.15

Champions Oncology

12/12/2023 21:04

Dec 12 (Reuters) - Champions Oncology Q2 adjusted EPS USD -0.15.
* Q2 EPS USD -0.15
* Q2 revenue USD 11.6 million
* Q2 income from operations USD -2 million
* Q2 adjusted EBITDA USD -1.4 million
* Q2 gross margin 42.8%